Chitosan-decorated and tripolyphosphate-crosslinked pH-sensitive niosomal nanogels for Controlled release of fluoropyrimidine 5-fluorouracil

被引:16
作者
Ahmed, Mohammed Mahmood [1 ]
Ameen, Muath Sheet Mohammed [2 ]
Abazari, Morteza [3 ]
Badeleh, Safa Momeni [4 ]
Rostamizadeh, Kobra [5 ]
Mohammed, Shahen Salih [1 ]
机构
[1] Univ Sulaimani, Coll Pharm, Dept Pharmaceut, Sulaimani, Iraq
[2] Knowledge Univ, Coll Pharm, Dept Pharm, Erbil, Kurdistan Regio, Iraq
[3] Zanjan Univ Med Sci, Sch Pharm, Dept Pharmaceut Nanotechnol, Zanjan, Iran
[4] Zanjan Univ Med Sci, Sch Pharm, Dept Food & Drug Control, Zanjan, Iran
[5] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Dept Pharmacol, Seattle, WA 98195 USA
关键词
Niosome; Nanogel; Chitosan; Cancer; 5-FU; LOADED SILICA NANOPARTICLES; TARGETED DELIVERY; NANOCARRIERS; FORMULATION;
D O I
10.1016/j.biopha.2023.114943
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In the present study, 5-fluorouracil-loaded niosomal nanoparticles were successfully prepared and coated with chitosan and subsequently crosslinked by tripolyphosphate to form niosomal nanogels. The prepared niosomal formulations were fully characterized for their particle size, zeta potential, particle morphology, drug entrap-ment efficiency, and in vitro drug release profile. The prepared niosomal nanocarriers exhibited nanoscale particle sizes of 165.35 & PLUSMN; 2.75-322.85 & PLUSMN; 2.75 nm. Chitosan-coated and TPP-crosslinked niosomes exhibited a slightly decreased in particle size and a switch of zeta potential from negative to positive values. In addition, high yield percentage, drug encapsulation efficiency, and drug loading values of 92.11 & PLUSMN; 2.07 %, 66.59 & PLUSMN; 6.06, and 4.65 & PLUSMN; 0.5 were obtained for chitosan-coated formulations, respectively. Moreover, lowering the rate of 5-FU in vitro release was achieved within 72 h by using chitosan-coated formulations. All prepared formulations revealed hemocompatible properties in hemolysis assay with less than 5 % hemolysis percentage at their higher possible concentrations (500 & mu;M and 1 mM). The cell viability by MTT assay showed higher anticancer activity against B16F10 cancerous cells and lower cytotoxicity toward NIH3T3 normal cells than control and pure 5-FU in the studied concentration range (10-100 & mu;M). Investigating the cell migration inhibition properties of fabricated formulations revealed similar results with in vitro cell viability assay with a higher migration inhibition rate for B16F10 cells than NIH3T3 cells, controls, and free 5-FU.
引用
收藏
页数:16
相关论文
共 73 条
[1]   Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study [J].
Abdelmonem, Rehab ;
Elhabal, Sammar E. ;
Abdelmalak, Nevine S. ;
El-Nabarawi, Mohamed A. ;
Teaima, Mahmoud H. .
PHARMACEUTICS, 2021, 13 (02) :1-20
[2]   Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update [J].
Abdulbaqi, Ibrahim M. ;
Abou Assi, Reem ;
Yaghmur, Anan ;
Darwis, Yusrida ;
Mohtar, Noratiqah ;
Parumasivam, Thaigarajan ;
Saqallah, Fadi G. ;
Wahab, Habibah A. .
PHARMACEUTICALS, 2021, 14 (08)
[3]  
Ahmed L., 2019, Int. J. Latest Technol. Eng., Manage. Appl. Sci., V8, P52
[4]   Hemolytic and cellular toxicology of a sulfanilamide-based nonionic surfactant: a niosomal carrier for hydrophobic drugs [J].
Ali, Imdad ;
Shah, Muhammad Raza ;
Yousuf, Sammer ;
Ahmed, Ashakil ;
Shah, Kiramat ;
Javed, Ibrahim .
TOXICOLOGY RESEARCH, 2018, 7 (05) :771-778
[5]   In vitro hemolysis:: Guidance for the pharmaceutical scientist [J].
Amin, Ketan ;
Dannenfelser, Rose-Marie .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (06) :1173-1176
[6]  
[Anonymous], 2017, Biological Evaluation of Medical DevicesPart 4: Selection of Tests for Interactions with Blood
[7]   Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction [J].
Arafat, Mohammad ;
Fouladian, Paris ;
Wignall, Anthony ;
Song, Yunmei ;
Parikh, Ankit ;
Albrecht, Hugo ;
Prestidge, Clive A. ;
Garg, Sanjay ;
Blencowe, Anton .
PHARMACEUTICS, 2021, 13 (01) :1-22
[8]   5-Fluorouracil Encapsulated Chitosan Nanoparticles for pH-Stimulated Drug Delivery: Evaluation of Controlled Release Kinetics [J].
Aydin, R. Seda Tigli ;
Pulat, Mehlika .
JOURNAL OF NANOMATERIALS, 2012, 2012
[9]   Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability [J].
Badran, Mohammad M. ;
Alomrani, Abdullah H. ;
Harisa, Gamaleldin I. ;
Ashour, Abdelkader E. ;
Kumar, Ashok ;
Yassin, Alaa Eldeen .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 :1461-1468
[10]   Anticancer effect of green tea extract (GTE)-Loaded pH-responsive niosome Coated with PEG against different cell lines [J].
Baranei, Mahmoud ;
Taheri, Ramezan Ali ;
Tirgar, Mahtab ;
Saeidi, Ardeshir ;
Oroojalian, Fatemeh ;
Uzun, Lokman ;
Asefnejad, Azadeh ;
Wurm, Frederik R. ;
Goodarzi, Vahabodin .
MATERIALS TODAY COMMUNICATIONS, 2021, 26